Effect of Position Change on Pain, Comfort and Vascular Complications After Coronary Angiography
1 other identifier
interventional
60
1 country
1
Brief Summary
Today, complementary and alternative treatments are frequently used to maintain health and well-being, reduce symptoms of diseases, and provide relaxation. Nurses contribute to the healing process by using pharmacological and nonpharmacological methods. Pharmacological methods cause nausea, vomiting, respiratory depression, gastrointestinal and urinary system complications in individuals. Therefore, nonpharmacological methods without side effects are gaining importance. Nonpharmacological methods are easy and simple nursing interventions that do not have side effects, are cost-effective, can be easily taught to the patient, reduce pain and anxiety. They can also be used in addition to pharmacological methods and are preferred in patients who do not take medication or are unwilling to take medication. Providing a safe position without vascular complications and back pain after the procedure is very important for both the patient and the nurse who cares for the patient. Existing studies on post-intervention position changes have reported low incidences of bleeding and back pain, resulting in higher levels of patient comfort and satisfaction. These studies evaluated different angles of elevating the head of the bed and recommended further studies to evaluate the possibility of shifting patients to other positions after transfemoral cardiac interventions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 25, 2025
CompletedFirst Posted
Study publicly available on registry
March 3, 2025
CompletedStudy Start
First participant enrolled
March 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 25, 2025
CompletedAugust 29, 2025
August 1, 2025
21 days
February 25, 2025
August 25, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Average Pain Score on Visual Analog Scale (VAS)
Pain will be measured using the Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (severe pain). Higher scores indicate more severe pain.
0 hour (baseline), 1st hour, 2nd hour, 3rd hour
Average Score on Immobilization Comfort Scale (ICS)
Comfort during immobilization will be measured using the Immobilization Comfort Scale (ICS), a 20-item Likert-type scale ranging from 1 (strongly disagree) to 6 (strongly agree). Higher scores indicate greater comfort. Cronbach's alpha in this study ranged from 0.77 to 0.84.
0 hour (baseline), 1st hour, 2nd hour, 3rd hour
Vascular Complication Score
Vascular complications will be assessed using the Oozing and Bleeding Scale and the Ecchymosis and Hematoma Formation Scale developed by Elsaman (2022). Categories include: no bleeding/ecchymosis/hematoma, oozing/bleeding \<2 cm², bleeding ≥2 cm², ecchymosis \<2 cm², hematoma ≥2 cm². Higher scores indicate more severe vascular complications.
0 hour (baseline), 1st hour, 2nd hour, 3rd hour
Study Arms (2)
back position group
EXPERIMENTALThe bed levels of the patients in the experimental group changed the patient's position every 2 hours immediately after catheter removal and sandbag placement in the following order: supine position with a 15° head angle, semi-Fowler position with a 30° head angle, and lateral right or left position with a 15° head angle.
Control group
NO INTERVENTIONNo intervention
Interventions
The bed levels of the patients in the experimental group changed the patient's position
Eligibility Criteria
You may qualify if:
- Over 18 years of age
- Agree to participate in the study
- Not undergoing emergency coronary angiography
- Not consuming coffee or hypnotic drugs at least 12 hours ago
- No history of chronic pain (e.g. arthritis)
- Not addicted to alcohol or drugs
- No psychological problems (such as depression, anxiety disorder)
- Not using anxiolytics
You may not qualify if:
- Not willing to participate in the study
- Developing delirium during the follow-up period
- Developing complications after coronary angiography (such as bleeding etc.)
- Arrhythmia
- Hemodynamic instability
- Hereditary bleeding disorders
- Platelet count less than 100,000/mm3
- Abnormal coagulation parameters (high INR and/or aPTT)
- History of percutaneous coronary intervention (PCI)
- Multiple or bilateral punctures in the femoral artery
- Presence of hematoma on arrival after the procedure
- Radial access
- Bleeding at the access site or at the access dressing site
- Body mass index (BMI) ≥ 35 kg/m2
- Back pain before treatment
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Necibe
Kütahya, 43000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Burcu NAL, PhD
Kütahya Health Sciences University, Faculty of Health Sciences
- STUDY DIRECTOR
Mehmet Ali ASTARCIOĞLU, Prof.
Kütahya Health Sciences University, Faculty of Health Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Patients will be divided into experimental and control groups. Patients will know that they are participating in the study and the interventions that will be applied to them, but they will be blinded by not knowing which group they are in. The study data will be collected by a second researcher who is blinded to the groups. In the statistical analysis of the data, the groups will be labeled as group 1 and group 2, and the third researcher will be blinded when evaluating the results. Thus, the third researcher will be blinded to the study groups. In order to avoid bias in the evaluation of the results, the first researcher who is not blinded will not participate in any stage of the evaluation process.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Nursing
Study Record Dates
First Submitted
February 25, 2025
First Posted
March 3, 2025
Study Start
March 25, 2025
Primary Completion
April 15, 2025
Study Completion
August 25, 2025
Last Updated
August 29, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share